Viewing Study NCT01063868


Ignite Creation Date: 2025-12-24 @ 5:41 PM
Ignite Modification Date: 2026-01-04 @ 3:43 AM
Study NCT ID: NCT01063868
Status: TERMINATED
Last Update Posted: 2014-03-04
First Post: 2010-02-04
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Long-term Safety Study With Tapentadol ER and Oxycodone CR in Patients With Moderate to Severe Pain Due to Chronic, Painful Diabetic Peripheral Neuropathy (DPN)
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CR016978
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View